An experimental drug has successfully reduced the risk of hip and spine fractures in two key patient populations: postmenopausal women and men being treated for prostate cancer
TIME.com: Top Stories, Time
Tue, 08/11/2009 - 9:45am
An experimental drug has successfully reduced the risk of hip and spine fractures in two key patient populations: postmenopausal women and men being treated for prostate cancer